Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions
- PMID: 37283275
- DOI: 10.1093/ehjci/jead096
Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions
Abstract
Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded dramatically over the last years, thanks to the developments and improvements of devices and imaging techniques, along with the increasing expertise of operators. Imaging, in particular echocardiography, is pivotal during patient selection, procedural monitoring, and follow-up. The imaging assessment of patients undergoing transcatheter interventions places demands on imagers that differ from those of the routine evaluation of patients with SHD, and there is a need for specific expertise for those working in the cath lab. In the context of the current rapid developments and growing use of SHD therapies, this document intends to update the previous consensus document and address new advancements in interventional imaging for access routes and treatment of patients with aortic stenosis and regurgitation, and mitral stenosis and regurgitation.
Keywords: interventional echocardiography; interventional imaging; structural heart disease; transcatheter aortic valve implantation—transcatheter mitral valve therapy.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: E.A.: speaker and proctoring fees, research and educational grant from Philips, Edwards, Abbott, GE, and Siemens. E.B.: Proctoring fees from Abbott. M.D.: speaker fees from Pfizer and have participated on advisory boards for Novartis. F.F.: speaker's fees from Philips. P.M.-H.: Shareholder of Neumann Medical Ltd. M.S.: lecturer/proctor for Abbott Vascular, Boston Scientific, Philips Healthcare, and Bioventrix inc. R.S.V.B.: Trials (un-paid): IIT IZKS University of Go¨ttingen, Abbott Vascular, Bioventrix, Boston Scientific, Edwards Lifesciences, Medtronic; Speaker/ Advisory: Abbott Lifesciences, Bioventrix, Boston Scientific, Cardiac Dimensions, Edwards Lifesciences, and Philips. J.-L.Z.: research grants from Abbott. Speaker fee Daichii Sankio, Pfizer. B.A.P.: research grants and lecture fees from GE Healthcare and Hitachi-Aloka.
Similar articles
-
The use of imaging in new transcatheter interventions: an EACVI review paper.Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):835-835af. doi: 10.1093/ehjci/jew043. Epub 2016 Jun 16. Eur Heart J Cardiovasc Imaging. 2016. PMID: 27311822 Review.
-
Role of Echocardiography in Transcatheter Valvular Heart Disease Interventions.Curr Cardiol Rep. 2017 Oct 27;19(12):128. doi: 10.1007/s11886-017-0942-y. Curr Cardiol Rep. 2017. PMID: 29075913 Review.
-
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium.Eur Heart J. 2015 Aug 1;36(29):1851-77. doi: 10.1093/eurheartj/ehv281. Epub 2015 Jul 13. Eur Heart J. 2015. PMID: 26170467 Review.
-
Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit.Curr Vasc Pharmacol. 2018 Jan 26;16(2):107-113. doi: 10.2174/1570161115666170406105753. Curr Vasc Pharmacol. 2018. PMID: 28393705 Review.
-
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.J Am Coll Cardiol. 2015 Jul 21;66(3):308-321. doi: 10.1016/j.jacc.2015.05.049. J Am Coll Cardiol. 2015. PMID: 26184623
Cited by
-
Echocardiographic Screening for Transcatheter Edge-to-Edge Mitral Valve Repair: Correlation Between Transthoracic and Transesophageal Assessment.J Cardiovasc Dev Dis. 2025 Apr 10;12(4):149. doi: 10.3390/jcdd12040149. J Cardiovasc Dev Dis. 2025. PMID: 40278208 Free PMC article.
-
Cardiac Magnetic Resonance for Structural Aortic Valve Stenosis Procedures.J Clin Med. 2024 Sep 1;13(17):5184. doi: 10.3390/jcm13175184. J Clin Med. 2024. PMID: 39274397 Free PMC article. Review.
-
Standardized 3D Transoesophageal Echocardiography Manoeuvre for Enhanced Tenting Height Evaluation During Transcatheter Mitral Valve Edge-to-Edge Repair.J Clin Med. 2024 Oct 30;13(21):6525. doi: 10.3390/jcm13216525. J Clin Med. 2024. PMID: 39518664 Free PMC article.
-
Early cognitive and quality of life changes after transfemoral transcatheter aortic valve replacement.Med Pharm Rep. 2025 Jul;98(3):311-319. doi: 10.15386/mpr-2885. Epub 2025 Jul 30. Med Pharm Rep. 2025. PMID: 40786196 Free PMC article.
-
The Other Side of the Coin: Transesophageal Echocardiography Complications following Cardiac Surgery and Transcatheter Structural Heart Interventions.J Clin Med. 2024 Jul 23;13(15):4291. doi: 10.3390/jcm13154291. J Clin Med. 2024. PMID: 39124557 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous